Somewhere between recycled meme coins and overhyped layer-2s projects, a new batch of projects is quietly stealing the ...

Crypto presales are heating up, with Lightchain AI and BlockDAG drawing serious attention from market watchers. Lightchain AI ...

As the dynamic world of cryptocurrencies continues to evolve and mature, savvy investors are looking for the moonshot potential to capitalise on high ROI in ...

Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

As Bitcoin (BTC) and Ethereum (ETH) cool off after their massive runs, all eyes are on the next wave of altcoins set to ...

The crypto market is buzzing with exciting developments, and presale crypto tokens are taking center stage.  Among the most ...

In this video, Shahzad Raza, MD, discusses safety and efficacy data from Nexicart-2, which studied the use of chimeric antigen receptor T-cell therapy in relapsed or refractory light chain amyloidosis ...

In this video, Shahzad Raza, MD, discusses teclistamab as a potential treatment for patients with relapsed or refractory systemic light chain amyloidosis.“Teclistamab has already been approved in ...

Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), a chronic inflammatory disease that affects nearly 3 million people ...

Topline data were announced from a phase 3 clinical program evaluating anselamimab in patients with Mayo stages 3a and 3b light chain (AL) amyloidosis.

Clene (NASDAQ: CLNN) , together with its subsidiary Clene Nanomedicine Inc., is preparing to initiate neurofilament biomarker analyses for its lead d ...